XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
RAMAT GAN, ISRAEL, Dec. 24, 2025 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or…
0,646$
-6,58%
Echtzeit-Aktienkurs XTL Biopharmaceuticals Ltd. (ADRs)
Bid:
Ask: